Skip to main content
. Author manuscript; available in PMC: 2017 Jan 19.
Published in final edited form as: J Am Coll Cardiol. 2016 Jan 19;67(2):174–189. doi: 10.1016/j.jacc.2015.10.072

TABLE 5.

Variables Predicting the Presence of RV-PV Dysfunction

Model 1
Model 2
Model 3
C-Statistic p Value C-Statistic p Value C-Statistic p Value
Model without metabolites 0.68 0.72 0.82
Kynurenine 0.76 0.007 0.80 0.004 0.86 0.03
Quinolinate 0.72 0.05 0.75 0.07 0.85 0.13
Anthranilate 0.71 0.11 0.74 0.10 0.87 0.01
Kynurenate 0.75 0.04 0.79 0.01 0.88 0.02
IDO score 0.74 0.01 0.79 0.006 0.87 0.01

Model 1: Consists of readily available clinical variables associated with pulmonary hypertension (age, sex, body mass index). Model 2: Adds pulmonary artery wedge pressure to model 1 variables. Model 3: Adds measured right ventricular ejection fraction; omits body mass index based on lack of significant association with any of the metabolite levels or pulmonary hypertension.

Abbreviations as in Table 2.